Income statement
USD
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | 79M | 85M | 64M | 57M | 31M |
| Gross Profit | 54M | 57M | 45M | 43M | 23M |
| Operating Income | -95M | -71M | -40M | -17M | -21M |
| EBITDA | -92M | -70M | -40M | -11M | -17M |
| Net Income | -98M | -72M | -42M | -18M | -23M |
| EPS (Diluted) | — | — | — | — | — |
Healthcare
Live Price
Offline$1.20
-5.88% today
1Y Change
—
Window
No data
Historical coverage is still loading
We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Berkeley Lights, Inc. (BLI) is a Healthcare stock with a market cap of $86.61M. The stock last traded around $1.20. Baseline metrics include revenue growth of -8.0%, EPS growth of -31.5%, a dividend yield of 0.0%. What stands out right now is revenue -8.0%, EPS -31.5%, free cash flow +19.3% with operating margin -120.3% and ROIC -50.9%. Valuation is more restrained than many high-expectation growth names at price/sales 1.1. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines BLI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
BLI
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
BLI Max Drawdown
—
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for BLI and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$31.3M
-44.8% YoY
FY Net Income
-$23.3M
-27.5% YoY
Free Cash Flow
-$21.0M
-10.5% YoY
Revenue Growth
-8.0%
EPS Growth
-31.5%
Gross Margin
68.4%
Net Margin
-124.7%
Income statement
USD
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | 79M | 85M | 64M | 57M | 31M |
| Gross Profit | 54M | 57M | 45M | 43M | 23M |
| Operating Income | -95M | -71M | -40M | -17M | -21M |
| EBITDA | -92M | -70M | -40M | -11M | -17M |
| Net Income | -98M | -72M | -42M | -18M | -23M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Cash & Equivalents | 87M | 178M | 233M | 81M | 100M |
| Total Assets | 226M | 287M | 300M | 131M | 134M |
| Total Liabilities | 84M | 79M | 55M | 47M | 36M |
| Shareholder Equity | 142M | 208M | 245M | 84M | 98M |
| Total Debt | 43M | 44M | 36M | 29M | 20M |
| Net Debt | -44M | -134M | -198M | -52M | -80M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
14M
-28.5% YoY
Capital Expenditures
7M
+11.9% YoY
Free Cash Flow
21M
-10.5% YoY
Key ratios
Gross Margin
68.4%
Operating Margin
-120.3%
Net Margin
-124.7%
ROE
-56.0%
Debt / Equity
0.30x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.